Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietmar Seiffert

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
The American Journal of Cardiology|December 18, 2019
Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)Stuart B Prenner, Anupam Kumar, Lei Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2016
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitorsVladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, et al.
British Journal of Clinical Pharmacology|January 19, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjectsVidya Perera, Joseph M Luettgen, Zhaoqing Wang, et al.
Blood|October 24, 2002
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopeniaDietmar Seiffert, Andrew M Stern, William Ebling, et al.
JACC. Basic to Translational Science|March 5, 2021
Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection FractionThomas C Hanff, Jordana B Cohen, Lei Zhao, et al.
Hypertension (Dallas, Tex. : 1979)|September 28, 2020
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart FailureJulio A Chirinos, Jordana B Cohen, Lei Zhao, et al.
Journal of Medicinal Chemistry|July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor ComplexXiaojun Zhang, Peter W Glunz, James A Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2006
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitorsLorin A Thompson, Ann Y Liauw, Mercy M Ramanjulu, et al.
Thrombosis and Haemostasis|March 20, 2015
Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liabilityJoseph M Metzger, Marija Tadin-Strapps, Anil Thankappan, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|January 21, 2017
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa InhibitorsJeremy M Richter, Daniel L Cheney, J Alex Bates, et al.
The American Journal of Cardiology|December 18, 2019
Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)Stuart B Prenner, Anupam Kumar, Lei Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2016
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitorsVladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, et al.
British Journal of Clinical Pharmacology|January 19, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjectsVidya Perera, Joseph M Luettgen, Zhaoqing Wang, et al.
Blood|October 24, 2002
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopeniaDietmar Seiffert, Andrew M Stern, William Ebling, et al.
JACC. Basic to Translational Science|March 5, 2021
Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection FractionThomas C Hanff, Jordana B Cohen, Lei Zhao, et al.
Hypertension (Dallas, Tex. : 1979)|September 28, 2020
Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart FailureJulio A Chirinos, Jordana B Cohen, Lei Zhao, et al.
Journal of Medicinal Chemistry|July 26, 2016
Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor ComplexXiaojun Zhang, Peter W Glunz, James A Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2006
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitorsLorin A Thompson, Ann Y Liauw, Mercy M Ramanjulu, et al.
Thrombosis and Haemostasis|March 20, 2015
Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liabilityJoseph M Metzger, Marija Tadin-Strapps, Anil Thankappan, et al.
Pageof 5